We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Pregnancy in Diabetes Audit Report - 2015Audit
- Publication Date:
- 21 Oct 2016
- Geographic Coverage:
- England, Wales
- Geographical Granularity:
- Hospital and Community Health Services, Hospital Trusts, NHS Trusts
- Date Range:
- 01 Jan 2015 to 31 Dec 2015
The National Pregnancy in Diabetes (NPID) Audit is part of the National Diabetes Audit (NDA) programme, and is commissioned by The Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit (NCA) programme.
The NPID 2015 report is the third annual report from a continuous audit of the quality of care and outcomes for women with diabetes who become pregnant. The audit looks at three key questions:
- Were women adequately prepared for pregnancy?
- Were adverse maternal outcomes during pregnancy minimised?
- Were adverse fetal/infant outcomes minimised?
This report includes data on women with diabetes with completed pregnancies between 1 January 2015 and 31 December 2015 and where the data was submitted to the audit by 12 February 2016.
In 2015, 3,044 pregnancies in 3,036 women with diabetes were recorded by 155 antenatal diabetes services in England, Wales and the Isle of Man. In addition to the national report, the NPID Audit has produced service level data for the first time.
• Only 16 per cent of women with Type 1 diabetes and 38 per cent of women with Type 2 diabetes had first trimester HbA1c <48 mmol/mol.
• 46 per cent of women with Type 1 diabetes and 23 per cent of women with Type 2 diabetes were taking 5mg folic acid prior to pregnancy.
Contact with the antenatal diabetes team:
• Only 36 per cent of women with Type 2 diabetes and 55 per cent of women with Type 1 diabetes had contact in the first 8 weeks of pregnancy.
· The stillbirth rate has reduced significantly since the 2002-03 CEMACH study for women with Type 1 and Type 2 diabetes (10.7 and 10.5 per 1,000 respectively), although it is still higher than in the general population (4.7 per 1,000 live and stillbirths).
· Preterm delivery, babies large for gestational age and admission to a neonatal unit were more common for women who had HbA1c at 24 weeks+ above 48 mmol/mol.